CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 7585612)

Published in Cancer Res on November 15, 1995

Authors

K Friedrichs1, F Franke, B W Lisboa, G Kügler, I Gille, H J Terpe, F Hölzel, H Maass, U Günthert

Author Affiliations

1: Department of Obstetrics and Gynecology, University of Hamburg, Germany.

Articles citing this

The normal structure and function of CD44 and its role in neoplasia. Mol Pathol (1998) 1.44

Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am J Pathol (2002) 1.26

In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver. Am J Pathol (2007) 1.25

CD44 and the adhesion of neoplastic cells. Mol Pathol (1997) 1.12

Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. Am J Pathol (2000) 0.98

Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol (1996) 0.95

CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition. PLoS One (2013) 0.94

Molecular studies into the role of CD44 variants in metastasis in gastric cancer. Mol Pathol (1999) 0.94

New concepts in breast cancer metastasis: tumor initiating cells and the microenvironment. Clin Exp Metastasis (2007) 0.93

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients. Diagn Pathol (2014) 0.92

CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast. J Clin Pathol (1999) 0.91

Clinical significance of pAKT and CD44v6 overexpression with breast cancer. J Cancer Res Clin Oncol (2010) 0.91

CD44 and HCELL: preventing hematogenous metastasis at step 1. FEBS Lett (2011) 0.88

High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer. Br J Cancer (1997) 0.87

CD44 isoform expression follows two alternative splicing pathways in breast tissue. Am J Pathol (1998) 0.86

Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications. Clin Exp Metastasis (2000) 0.86

KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia (2014) 0.86

TRA-1-60(+), SSEA-4(+), Oct4A(+), Nanog(+) Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Ovaries. J Stem Cell Res Ther (2012) 0.85

Frontiers in Suicide Gene Therapy of Cancer. J Genet Syndr Gene Ther (2012) 0.83

Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients. J Cancer Res Clin Oncol (2008) 0.83

Promising noninvasive cellular phenotype in prostate cancer cells knockdown of matrix metalloproteinase 9. ScientificWorldJournal (2013) 0.82

CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast. J Clin Pathol (2005) 0.81

Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung. J Cancer Res Clin Oncol (2015) 0.78

Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: facilitated retention in the lung vasculature. Proc Natl Acad Sci U S A (1997) 0.76

Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model. Oncol Lett (2016) 0.75

CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma. Virchows Arch (2016) 0.75

Articles by these authors

Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton. J Cell Biol (1999) 2.60

CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res (1991) 2.36

Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J Cell Biol (1996) 2.27

Expression and modulation of CD44 variant isoforms in humans. J Cell Biol (1994) 2.17

Restriction and modification in Bacillus subtilis: nucleotide sequence, functional organization and product of the DNA methyltransferase gene of bacteriophage SPR. Gene (1984) 1.98

DNA methyltransferases affecting the sequence 5'CCGG. Nucleic Acids Res (1981) 1.80

De-novo expression of CD44 and survival in gastric cancer. Lancet (1993) 1.75

Restriction and modification in Bacillus subtilis: DNA methylation potential of the related bacteriophages Z, SPR, SP beta, phi 3T, and rho 11. J Virol (1983) 1.72

High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res (1995) 1.65

Restriction and modification in Bacillus subtilis: identification of a gene in the temperate phage SP beta coding for a BsuR specific modification methyltransferase. Mol Gen Genet (1980) 1.62

CD44 isoforms in prognosis of breast cancer. Lancet (1995) 1.47

[Effects of clomid isomers A and B on protein synthesis of various organs in newborn female guinea pigs]. Arch Gynakol (1971) 1.39

Restriction and modification in Bacillus subtilis. Localization of the methylated nucleotide in the BsuRI recognition sequence. Eur J Biochem (1978) 1.37

Estrogen receptors in human breast cancer tissue. Am J Obstet Gynecol (1972) 1.36

Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J Exp Med (2000) 1.31

Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol (1998) 1.31

Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J Exp Med (1995) 1.30

Cloning and expression of Bacillus subtilis phage DNA methyltransferase genes in Escherichia coli and B. subtilis. Gene (1986) 1.27

A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res (1993) 1.26

Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Histopathology (1999) 1.25

DNA methyltransferases of Bacillus subtilis and its bacteriophages. Curr Top Microbiol Immunol (1984) 1.25

Comparative genomic hybridization (CGH) analysis of neuroblastomas--an important methodological approach in paediatric tumour pathology. J Pathol (1997) 1.24

CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood (1995) 1.21

Karyotype analyses of 20 human glioma cell lines. Acta Neurochir (Wien) (1994) 1.20

Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res (2001) 1.19

Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer. Gut (2008) 1.19

Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype. Int J Cancer (1999) 1.16

CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues. Histochemistry (1994) 1.16

Gains and losses of CD44 expression during breast carcinogenesis and tumour progression. Histopathology (1998) 1.15

CD44 isoforms during differentiation and development. Bioessays (1995) 1.15

Restriction and modification in Bacillus subtilis: two DNA methyltransferases with BsuRI specificity. I. Purification and physical properties. J Biol Chem (1981) 1.15

A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms. Cell Death Differ (2006) 1.14

Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer. Breast Cancer Res Treat (2008) 1.12

Adenocarcinoma of the ileoanal pouch for ulcerative colitis--a complication of severe chronic atrophic pouchitis? Int J Colorectal Dis (2005) 1.12

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients. Eur J Cancer (2013) 1.12

Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland. J Histochem Cytochem (1997) 1.11

Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int J Cancer (1990) 1.11

Multispecific DNA methyltransferases from Bacillus subtilis phages. Properties of wild-type and various mutant enzymes with altered DNA affinity. Eur J Biochem (1986) 1.11

Restriction and modification in Bacillus subtilis: two DNA methyltransferases with BsuRI specificity. II. Catalytic properties, substrate specificity, and mode of action. J Biol Chem (1981) 1.11

Are CD44 variant isoforms involved in human tumour progression? Cancer Surv (1995) 1.10

Patterns of chromosomal imbalances in muscle invasive bladder cancer. Int J Oncol (2000) 1.10

Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. Endoscopy (2002) 1.10

Human breast cancer: frequent p53 allele loss and protein overexpression. Hum Genet (1993) 1.08

Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst (1983) 1.08

In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells. Cancer Res (2000) 1.06

In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen, and prolactin. J Natl Cancer Inst (1984) 1.06

Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody. J Immunol (1998) 1.05

Restriction and modification in B. subtilis. The biochemical basis of modification against endo R. Bsu R restriction. Mol Gen Genet (1975) 1.05

Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples. Cancer Res (1986) 1.03

Bacillus subtilis phage SPR codes for a DNA methyltransferase with triple sequence specificity. Nucleic Acids Res (1987) 1.01

Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension (1995) 1.01

High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res (1993) 1.00

Expression of cell adhesion molecules alpha-2, alpha-5 and alpha-6 integrin, E-cadherin, N-CAM and CD-44 in renal cell carcinomas. An immunohistochemical study. Virchows Arch A Pathol Anat Histopathol (1993) 0.97

A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood (1998) 0.97

Effects of oestrogen and the antioestrogens, tamoxifen and LY117018, on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line. J Steroid Biochem (1989) 0.97

Influence of melatonin treatment on human circadian rhythmicity before and after a simulated 9-hr time shift. J Biol Rhythms (1991) 0.96

Unusual behaviour of SPO1 DNA with respect to restriction and modification enzymes recognizing the sequence 5'-G-G-C-C. Mol Gen Genet (1980) 0.96

[Behavior of enzyme activities, especially of thymidylate synthetase, after hepatectomy and after application of trenimon and actinomycin]. Z Krebsforsch (1970) 0.96

Restriction and modification in Bacillus subtilis: gene coding for a BsuR-specific modification methyltransferase in the temperate bacteriophage phi 3T. J Virol (1981) 0.95

Integration of progeny simian virus 40 DNA into the host cell genome. J Mol Biol (1974) 0.95

Specific binding of oestradiol in human uterine tissue. Acta Endocrinol (Copenh) (1973) 0.94

Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J Pathol (1994) 0.94

[Breast cancer]. Geburtshilfe Frauenheilkd (1968) 0.94

Steroid hormone receptors in human breast cancer and the clinical significance. J Steroid Biochem (1975) 0.92

Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study. Br Med J (1975) 0.92

Expression of CD44 isoforms is increased in the airway epithelium of asthmatic subjects. Am J Respir Cell Mol Biol (1997) 0.91

Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. Oral Oncol (1999) 0.91

Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study. Br Med J (1975) 0.91

Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide. Mult Scler (1998) 0.91

Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome. Med Pediatr Oncol (2001) 0.91

Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol (1996) 0.90

Restriction and modification in Bacillus subtilis: inducibility of a DNA methylating activity in nonmodifying cells. J Virol (1976) 0.89

CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells. Leukemia (2002) 0.88

[The effect of partial hepatectomies on the hepatoma rate after administration of diethyl-nitrosamine]. Z Naturforsch B (1970) 0.88

Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis. Am J Respir Cell Mol Biol (1995) 0.88

Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas. Br J Cancer (1998) 0.87

Androgen sensitivity of the new human breast cancer cell line MFM-223. Cancer Res (1991) 0.87

In vitro methylation of the BsuRI (5'-GGCC-3') sites in the E2a region of adenovirus type 2 DNA does not affect expression in Xenopus laevis oocytes. Mol Cell Biol (1982) 0.87

Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters. Arch Gynecol Obstet (1996) 0.87

Tumour karyotype may be important in the prognosis of human neuroblastoma. J Cancer Res Clin Oncol (1986) 0.86

Endotracheal placement of balloon-expanded stents: an experimental study in rabbits. Radiology (1997) 0.86

The depot GnRH analogue goserelin in the treatment of premenopausal patients with metastatic breast cancer--a 5-year experience and further endocrine therapies. Cooperative German Zoladex Study Group. Onkologie (1991) 0.86

Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up. Int J Radiat Oncol Biol Phys (1997) 0.86

The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer. Cancer (1980) 0.86

In vitro modulation of prolactin binding to human mammary carcinoma cells by steroid hormones and prolactin. J Clin Endocrinol Metab (1985) 0.85

CD44v7 ligation downregulates the inflammatory immune response in Crohn's disease patients by apoptosis induction in mononuclear cells from the lamina propria. Cell Death Differ (2007) 0.85

Is the DNA of virus T7 methylated? J Gen Virol (1979) 0.85

[Epidemiologic studies of malignant neoplasms in Hamburg 1960-1962]. Z Krebsforsch (1969) 0.85

The cellular basis of metastasis. World J Urol (1996) 0.85

Evolution of tumor cytogenetic aberrations and N-myc oncogene amplification in a case of disseminated neuroblastoma. Cancer Genet Cytogenet (1987) 0.85

CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma. Leuk Res (2001) 0.84

Paget's disease of the vulva with underlying apocrine adenocarcinoma and local lymph node invasion. Pathol Res Pract (1981) 0.84

Identical chromosome 1p breakpoint abnormality in both the tumor and the constitutional karyotype of a patient with neuroblastoma. Cancer Genet Cytogenet (1988) 0.83

Measles outbreak in the Provence-Alpes-Côte d'Azur region, France, January-July 2003. Euro Surveill (2005) 0.83